
About SiriusXT
SiriusXT is a company based in Dublin (Ireland) founded in 2015. SiriusXT has raised $3.33 million across 8 funding rounds from investors including European Union and Emergency Interoperability Consortium. SiriusXT offers products and services including SXT100. SiriusXT operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, SpectraWAVE and Ionpath, among others.
- Headquarter Dublin, Ireland
- SectorsHealthcare
- Website siriusxt.com
- Social LinkedIn X YouTube
- Legal Name Siriusxt Ltd.
- Total Equity Funding$3.33M (USD)
in 8 rounds
- Latest Funding Round$975.07K (USD), Grant
Jan 2021
- InvestorsEuropean Union
& 1 more
Products & Services of SiriusXT
SiriusXT offers a comprehensive portfolio of products and services, including SXT100.
Enables high-resolution 3D imaging of hydrated cells for research.
Apps and channels of SiriusXT
its YouTube channel SiriusXT has 24 subscribers and 9 videos.
Videos from SiriusXT
The most watched videos on SiriusXT's YouTube channel, SiriusXT (24 subscribers). Click a video to play it here.
More on SiriusXT.
Funding Insights of SiriusXT
SiriusXT has successfully raised a total of $3.33M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $975.07 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.33M
- Total Rounds 8
- Last Round Grant β $975,066
- First Round $53,650
(Nov 2015)
- Investors Count 2
All 8 funding rounds of SiriusXT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $975,066 | Grant | β | β | |
| Aug 2020 | $1.78M | Grant | β | β | |
| Jun 2020 | – | Series A | β | Emergency Interoperability Consortium | β |
| Mar 2017 | $185,270 | Grant | β | β | |
| Jan 2017 | $183,205 | Grant | β | β | |
| Jan 2017 | $3.16M | Grant | β | β | |
| Aug 2016 | $3.33M | Series A | β | β | β |
| Nov 2015 | $53,650 | Grant | β | β | β |
2 investors in total: 2 institutional.
Investors in SiriusXT
SiriusXT has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Emergency Interoperability Consortium.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
- | – | eic.org | - |
Investor details for SiriusXT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SiriusXT
11 people are tracked at SiriusXT (3 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Fergal O'Reilly | Chief Scientist | Leadership |
Sergey Kapishnikov | Director Of Imaging Applications | Leadership |
Paul Sheridan | Chief Technology Officer | Leadership |
Alberto Manzoni | Sr. Software Engineer | Team |
Martina Donnellan | Senior Instrumentation Scientist | Team |
William Fyans | Engneering Manager | Team |
Fionán Tierney | Senior Design Engineer | Team |
Stephen O'Connor | Instrumentation Scientist | Team |
Catherine Boothman | Software Developer & Data Scientist | Team |
Conal McIntyre | Instrument Scientist | Team |
Síofra Ní Lochlainn | Mechanical Design Engineer | Team |
Complete people profiles for SiriusXT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SiriusXT
3 dated milestones of SiriusXT across 6 years, from founding to its latest funding, stage changes and deals.
- Founded SiriusXT is founded.
- Funding First funding round of $54K.
- Funding Latest funding round, Grant, of $975K.
Competitors of SiriusXT
SiriusXT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, SpectraWAVE and Ionpath, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| oxinst.com | 1959 | Abingdon, United Kingdom | – | 2,027 | Technology tools and systems for molecular scale are developed. | |
| leica-microsystems.com | 1914 | Wetzlar, Germany | – | 67 | Imaging solutions for macro, micro, and nano structures are provided. | |
| iba-worldwide.com | 1986 | – | $27.32M | – | Innovative solutions for cancer treatment and industrial applications are provided by IBA. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. | |
| invenio-imaging.com | 2012 | Santa Clara, United States | $7.5M | – | Provider of a tissue imagine software and hardware solution for research diagnosis | |
| chromacitylasers.com | 2013 | Edinburgh, United Kingdom | $4.93M | 12 | Tunable fiber lasers are provided for industrial and scientific applications. | |
| lynceantech.com | 2002 | Fremont, United States | $26.91M | 39 | Delivers advanced imaging systems using local synchrotron x-ray sources for scientific and industrial applications. | |
| kfbio.cn | 2011 | Yuyao, China | $28.98M | – | Digital pathology systems are developed for image analysis and diagnosis. |
Detailed competitors of SiriusXT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SiriusXT
The website of SiriusXT (siriusxt.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▼ 12.7% vs previous month
Latest news on Siriusxt
Complete news archive for SiriusXT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to SiriusXT
10 companies that operate in the same segment as SiriusXT (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SiriusXT
SiriusXT was founded in 2015.
SiriusXT is headquartered in Dublin, Ireland.
SiriusXT is a funded company, having raised a total of $3.33M across 8 funding rounds to date. The company's 1st funding round was a Grant of $53.65K, raised on Nov 2015.
SiriusXT was founded in 2015 in Dublin, Ireland, within the life sciences sector. X-ray based solutions for 3D imaging of biological cells are developed by the company. A proprietary SXT system, functioning as a soft X-ray microscope with vacuum-based laser-produced plasma sources, is offered as a benchtop instrument. Cells are imaged in their native, fully hydrated state. Customers encompass biopharma firms, diagnostics entities, and life science researchers.
SiriusXT's top competitors include Oxford Instruments, Leica Microsystems and IBA.
SiriusXT offers SXT100.
SiriusXT has 2 investors. Key investors include European Union, and Emergency Interoperability Consortium.
SiriusXT operates through Siriusxt Ltd..
